Trials / Completed
CompletedNCT02290665
Localized Therapeutics for the Treatment of Gastrointestinal Disorders
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the patient preference for a biocompatible thermosensitive solution-gel versus water or saline (liquid) enema. The thermosensitive solution-gel is comprised of poloxamer, an inactive compound that is designated as GRAS (generally recognized as safe) by FDA. It could subsequently be used as a medium for drug delivery. The poloxamer (gel) is administered to study participants in order to assess preference and proximal distribution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Thermosensitive gel rectal formulation | |
| OTHER | Saline enema |
Timeline
- Start date
- 2015-01-30
- Primary completion
- 2015-09-28
- Completion
- 2015-09-28
- First posted
- 2014-11-14
- Last updated
- 2018-08-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02290665. Inclusion in this directory is not an endorsement.